RITUXIMAB-ABBS for Chronic lymphocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 94 adverse event reports in the FDA FAERS database where RITUXIMAB-ABBS was used for Chronic lymphocytic leukaemia.
Most Reported Side Effects for RITUXIMAB-ABBS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,167 | 49.9% | 125 | 256 |
| Intentional product use issue | 273 | 6.3% | 77 | 124 |
| Dyspnoea | 208 | 4.8% | 65 | 104 |
| Pain | 205 | 4.7% | 60 | 102 |
| Rheumatoid arthritis | 202 | 4.7% | 64 | 109 |
| Intentional dose omission | 196 | 4.5% | 14 | 76 |
| Fatigue | 195 | 4.5% | 60 | 94 |
| Drug ineffective | 186 | 4.3% | 59 | 73 |
| Hypertension | 183 | 4.2% | 64 | 99 |
| Infusion related reaction | 183 | 4.2% | 55 | 76 |
| Rash | 183 | 4.2% | 51 | 102 |
| Pyrexia | 180 | 4.1% | 50 | 119 |
| Nausea | 170 | 3.9% | 36 | 74 |
| Death | 167 | 3.8% | 167 | 19 |
| Headache | 167 | 3.8% | 65 | 78 |
Other Indications for RITUXIMAB-ABBS
Rheumatoid arthritis (820)
Product used for unknown indication (373)
Diffuse large b-cell lymphoma (288)
Immune thrombocytopenia (235)
Vasculitis (151)
B-cell lymphoma (133)
Systemic lupus erythematosus (129)
Mantle cell lymphoma (123)
Multiple sclerosis (120)
Non-hodgkin's lymphoma (111)
Other Drugs Used for Chronic lymphocytic leukaemia
IBRUTINIB (37,003)
VENETOCLAX (14,194)
RITUXIMAB (7,231)
OBINUTUZUMAB (4,557)
ACALABRUTINIB (4,515)
IDELALISIB (3,537)
CYCLOPHOSPHAMIDE (3,085)
FLUDARABINE (2,777)
BENDAMUSTINE (2,561)
CHLORAMBUCIL (1,242)